Asterriquinones could potentially treat neurodegenerative diseases such as Alzheimer’s and Parkinson’s by activating tyrosine kinases (TrkA, TrkB and TrkC) receptors [43,44,45]. The gene discussed is NTRK2; the disease is Parkinsonism.